英诺特: 2024年年度股东大会决议公告

Core Viewpoint - The shareholder meeting of Beijing Innotech Biotechnology Co., Ltd. was held on May 22, 2025, with all proposed resolutions passing successfully, indicating strong shareholder support and compliance with legal requirements [1][2][3]. Meeting Details - The meeting took place at the conference room on the 7th floor of Building 2, No. 1 Haiying Road, Fengtai District, Beijing [1]. - A total of 64 ordinary shareholders attended, holding 72,974,432 voting rights, which accounted for 54.3185% of the company's total voting rights [1]. Voting Results - All non-cumulative voting proposals were approved with significant majority support: - Proposal votes: 72,937,802 in favor (99.9498%), 34,230 against (0.0469%), and 2,400 abstentions (0.0033%) [1][2]. - Similar voting patterns were observed across multiple proposals, consistently showing over 99% approval from ordinary shareholders [2][3]. Legal Compliance - The meeting's convening and voting procedures adhered to the requirements set forth by the Company Law of the People's Republic of China and the company's articles of association, ensuring the legitimacy of the proceedings [1][3].